Press Releases Sequana Medical N.V.

Equities

SEQUA

BE0974340722

Market Closed - Euronext Bruxelles Other stock markets 11:17:22 2024-06-12 am EDT			5-day change	1st Jan Change
1.47 ^EUR	+0.68%		-3.29%	-63.25%

Jun. 06	Sequana Medical Announces Data on Alfapump® Safety and Quality of Life to Be Presented At EASL Congress 2024	CI
Apr. 03	Sequana Medical Announces Strong Data from DSR Proof-of-Concept Studies in Heart Failure Published in European Journal of Heart Failure	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sequana Medical announces data on alfapump safety and quality of life to be presented at EASL Congress 2024	Jun. 07	AQ
Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump	May. 23	AQ
Sequana Medical N : Draft Remuneration Policy	Apr. 24	PU
Advice of the ad hoc committee of independent directors in accordance with Article 7:179 of the Belgian Companies and Associations Code	Apr. 24	PU
Report of the Board of Directors in accordance with Articles 7:179 and 7:197 of the Belgian Companies and Associations Code	Apr. 22	PU
Special Report of the Board of Directors in accordance with Article 7:199 of the Belgian Companies and Associations Code	Apr. 22	PU
Sequana Medical N : Report of the Board of Directors on the annual accounts for the year ended 31 December 2023	Apr. 22	PU
Sequana Medical N : Statutory annual accounts for the year ended 31 December 2023	Apr. 22	PU
Sequana Medical N : Statutory auditor’s report on the consolidated accounts for the year ended 31 December 2023	Apr. 22	PU
Sequana Medical N : Statutory auditor’s report on the annual accounts for the year ended 31 December 2023	Apr. 22	PU
Sequana Medical submits Premarket Approval application to US FDA for alfapump in recurrent or refractory ascites due to liver cirrhosis	Dec. 29	AQ
Sequana Medical N : announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure	Nov. 29	PU
Sequana Medical N : announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission	23-10-19	PU
Sequana Medical N : announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome	23-10-18	PU
Sequana Medical N : announces Extraordinary General Meeting of Shareholders on 10 November 2023	23-10-06	PU
Sequana Medical N : Special report of the Board of Directors	23-10-05	PU
Sequana Medical N : ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES	23-10-05	PU
Sequana Medical N : announces H1 2023 results and provides business update	23-09-14	PU
Sequana Medical N : 2023 Half Year Report	23-09-14	PU
Sequana Medical N : Notice of 2023 Half-year Results and Business Update	23-09-06	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sequana Medical N.V.

Equities

SEQUA

BE0974340722

Press Releases

Filters